Nuvectra® to Present at 39th Annual Cowen Healthcare Conference

PLANO, Texas, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that Fred Parks, PhD, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to present at the upcoming 39th Annual Cowen Healthcare Conference in Boston, Massachusetts.

Event:             39^th Annual Cowen Healthcare Conference
Date:               Tuesday, March 12, 2019
Time:              11:20am ET
Format:           Presentation and 1x1s meetings
Location:        Boston Marriott Copley Place, Boston, MA

Webcasts of the Company’s fireside chats will be available by visiting the investor relations section of Nuvectra’s website at www.nuvectramed.com. Webcast replays of the presentations will be available for 90 days.

About Nuvectra Corporation

Nuvectra^® is a neurostimulation company committed to helping physicians improve the lives of people with chronic conditions. The Algovita^® Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and FDA approved for the treatment of chronic intractable pain of the trunk and/or limbs. Our innovative technology platform also has capabilities under development to support other indications such as sacral neuromodulation (SNM) for the treatment of overactive bladder, and deep brain stimulation (DBS) for the treatment of Parkinson’s Disease. Visit the Nuvectra website at www.nuvectramed.com.

Company Contacts:                                                                                                                             Investor Contacts:
Nuvectra Corporation                                                                                                                          The Ruth Group                  

Walter Berger, COO & CFO                                                                                                                   Tram Bui / Brian Johnston
(214) 474-3102                                                                                                                                       (646) 536-7035 / 7028                           
wberger@nuvectramed.com                                                                                                                  investors@nuvectramed.com